+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Involvement of Cd4+ Th1 Cells in Systemic Immunity Protective against Primary and Secondary Challenges with Trypanosoma cruzi



Involvement of Cd4+ Th1 Cells in Systemic Immunity Protective against Primary and Secondary Challenges with Trypanosoma cruzi



Infection and Immunity 68(1): 197-204




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067647915

Download citation: RISBibTeXText

DOI: 10.1128/iai.68.1.197-204.2000


Related references

Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infection and Immunity 68(1): 197-204, 1999

Type 1 immunity protects against both mucosal and systemic Trypanosoma cruzi challenges. FASEB Journal 14(6): A948, April 20, 2000

Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infection and Immunity 70(12): 6715-6725, 2002

Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges. Infection and Immunity 78(3): 1333-1338, 2010

Dendritic cells devoid of IL-10 induce protective immunity against the protozoan parasite Trypanosoma cruzi. Vaccine 28(46): 7407-7413, 2011

A SCID mouse model demonstrates the absolute requirement of CD4+ T cells for protective immunity against Trypanosoma cruzi. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 350, 1995

Activation of Natural Killer T Cells by -Galactosylceramide Impairs Dna Vaccine-Induced Protective Immunity against Trypanosoma cruzi. Infection and Immunity 71(3): 1234-1241, 2003

Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. Journal of Immunology 179(10): 6889-6900, 2007

Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi. Infection and Immunity 71(3): 1234-1241, 2003

Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion. Journal of Immunology 194(4): 1806-1818, 2015

Kinetics of Trypanosoma cruzi infection in guinea-pigs, with special reference to the involvement of epidermal Langerhans' cells in the induction of immunity. Parasitology 123(Pt 4): 373-380, 2001

Protective immunity against Trypanosoma cruzi. Memorias do Instituto Oswaldo Cruz 104 Suppl 1: 288-294, 2010

Effects of SEB administration on protective immunity against Trypanosoma cruzi. Memorias do Instituto Oswaldo Cruz 92(SUPPL 1): 224, 1997

Protective cross-immunity between Trypanosoma cruzi and T. lewisi. Revista do Instituto de Medicina Tropical de Sao Paulo 13(1): 31-36, 1971

Cruzipain induces protective immunity against Trypanosoma cruzi. FASEB Journal 13(4 PART 1): A633, March 12, 1999